Smoking rates point to promoting cessation
This article was originally published in The Tan Sheet
Research showing smoking rates of U.S. adults are not declining could elevate FDA's authority to approve smoking-cessation products under the tobacco control act. The Centers for Disease Control and Prevention Nov. 13 said data from the 2008 National Health Interview Survey show little to no change in smoking rates in the past five years. The study found 46 million U.S. people (20.6 percent) were smokers in 2008, essentially the same as the 2004 rate of 20.9 percent. The Family Smoking Prevention and Tobacco Control Act directs FDA to consider changing the way it reviews smoking cessation products, which would allow the agency to create opportunities for new products and expand markets for existing products (1"The Tan Sheet" Sept. 7, 2009)
You may also be interested in...
The tobacco control act prompts FDA to consider new indications - such as smoking reduction - for smoking cessation products, which could lead to new criteria for application approval
The failure of the SGLT2 inhibitor is not unexpected, but allays any concerns that it could have worsened outcomes for patients with hypertension or heart disease.
After a year that French industry association Gemme says has demonstrated the importance of a sustainable generics sector, the market continued to grow purely due to the contribution made by newly genericized molecules.